search
Back to results

An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients

Primary Purpose

Cavities of Teeth

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
OpalSeal
TransbondXT
Sponsored by
Virginia Commonwealth University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cavities of Teeth

Eligibility Criteria

10 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients age 10 and older seeking treatment at the VCU Orthodontics Clinic who require extraction of at least 2 teeth for orthodontic purposes
  • Such teeth should be free of any developmental defects

Exclusion Criteria:

  • Patients under 10 years of age
  • Patients with defective teeth
  • Those who cannot provide consent/assent OR not able to follow research protocols
  • Protected population (prisoners)

Sites / Locations

  • School of Dentistry, Virginia Commonwealth University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

OpalSeal

Transbond XT

Arm Description

OpalSeal will be applied to the buccal surfaces of to-be-extracted teeth on one side of the mouth which will be determined randomly for each participant during bonding of orthodontic brackets, or to the proximal surfaces following IPR in accordance to manufacturer instructions. Since OpalSeal has fluoride releasing capability, this would be experimental arm

TransbondXT will be applied to the buccal surfaces of to-be-extracted teeth on the other side of the mouth which will be determined based on which side received OpalSeal for each participant during bonding of orthodontic brackets, or to the proximal surfaces following IPR in accordance to manufacturer instructions. Transbond XT does not have fluoride and hence would be considered as a placebo.

Outcomes

Primary Outcome Measures

Loss of Mineral Density in the Enamel
Teeth will be subjected to microCT to assess the extent of demineralization. Loss of mineral density will be measured as depth of lesions

Secondary Outcome Measures

Surface Topography and Hardness
Scanning electron microscopy and atomic force microscopy will be used to evaluate the protective effect of OpalSeal
Retention of OpalSeal
The protective effects of OpalSeal is subject to its retention at the site of application. Since OpalSeal fluoresces under black light, its retention will be evaluated

Full Information

First Posted
October 25, 2018
Last Updated
February 24, 2020
Sponsor
Virginia Commonwealth University
search

1. Study Identification

Unique Protocol Identification Number
NCT03722264
Brief Title
An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients
Official Title
An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients. A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
November 16, 2017 (Actual)
Primary Completion Date
April 12, 2019 (Actual)
Study Completion Date
April 12, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Virginia Commonwealth University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No

5. Study Description

Brief Summary
Fluoride is very effective in preventing dental decay (cavities) when applied in the form of a varnish on tooth surfaces. The purpose of this study is to verify if fluoride-releasing primer (OpalSeal) offers more protection against early dental decay (cavity) compared to conventional primer (Transbond XT) during treatment with braces.
Detailed Description
Primers are a type of 'glue' routinely used in orthodontics to attach brackets (metallic components) to the teeth. OpalSeal is a fluoride-releasing primer that has the potential to reduce cavities in patients receiving braces. Orthodontic patients are at particular risk of developing two types of early carious lesions (decay): Around the brackets called White Spot Lesions and Along the sides of the teeth after slenderization procedure called inter-proximal reduction (IPR). Our research questions are: Can OpalSeal offer protection against white spot lesions (WSL) around the brackets? Can OpalSeal offer protection against decay on the sides of teeth following IPR?

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cavities of Teeth

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Participants have at least two teeth planned for extraction on either side of the mouth. The study will use a split-mouth design with random assignments for intervention (OpalSeal) on one tooth.
Masking
ParticipantOutcomes Assessor
Masking Description
Opalseal and TransbondXT are identical in color, consistency and application allowing random assignments as well as patient blinding. The outcomes assessor will also be blinded to the groups assignments.
Allocation
Randomized
Enrollment
12 (Actual)

8. Arms, Groups, and Interventions

Arm Title
OpalSeal
Arm Type
Experimental
Arm Description
OpalSeal will be applied to the buccal surfaces of to-be-extracted teeth on one side of the mouth which will be determined randomly for each participant during bonding of orthodontic brackets, or to the proximal surfaces following IPR in accordance to manufacturer instructions. Since OpalSeal has fluoride releasing capability, this would be experimental arm
Arm Title
Transbond XT
Arm Type
Placebo Comparator
Arm Description
TransbondXT will be applied to the buccal surfaces of to-be-extracted teeth on the other side of the mouth which will be determined based on which side received OpalSeal for each participant during bonding of orthodontic brackets, or to the proximal surfaces following IPR in accordance to manufacturer instructions. Transbond XT does not have fluoride and hence would be considered as a placebo.
Intervention Type
Device
Intervention Name(s)
OpalSeal
Intervention Description
OpalSeal is a fluoride releasing orthodontic primer that is FDA approved for use during bonding of orthodontic brackets
Intervention Type
Device
Intervention Name(s)
TransbondXT
Intervention Description
Transbond is a primer used to bond orthodontic brackets that does not contain fluoride
Primary Outcome Measure Information:
Title
Loss of Mineral Density in the Enamel
Description
Teeth will be subjected to microCT to assess the extent of demineralization. Loss of mineral density will be measured as depth of lesions
Time Frame
Time from initial bonding to extraction (max 90 days)
Secondary Outcome Measure Information:
Title
Surface Topography and Hardness
Description
Scanning electron microscopy and atomic force microscopy will be used to evaluate the protective effect of OpalSeal
Time Frame
Time from initial bonding to extraction (max 90 days)
Title
Retention of OpalSeal
Description
The protective effects of OpalSeal is subject to its retention at the site of application. Since OpalSeal fluoresces under black light, its retention will be evaluated
Time Frame
Time from initial bonding to extraction (max 90 days)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients age 10 and older seeking treatment at the VCU Orthodontics Clinic who require extraction of at least 2 teeth for orthodontic purposes Such teeth should be free of any developmental defects Exclusion Criteria: Patients under 10 years of age Patients with defective teeth Those who cannot provide consent/assent OR not able to follow research protocols Protected population (prisoners)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Parthasarathy Madurantakam, DDS
Organizational Affiliation
Virginia Commonwealth University
Official's Role
Principal Investigator
Facility Information:
Facility Name
School of Dentistry, Virginia Commonwealth University
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23298
Country
United States

12. IPD Sharing Statement

Learn more about this trial

An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients

We'll reach out to this number within 24 hrs